These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency. Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497 [No Abstract] [Full Text] [Related]
3. Diagnosis of idiopathic growth hormone deficiency: contributions of data on the acid-labile subunit, insulin-like growth factor (IGF)-I and-II, and IGF binding protein-3. Trivin C; Souberbielle JC; Aubertin G; Lawson-Body E; Adan L; Brauner R J Pediatr Endocrinol Metab; 2006 Apr; 19(4):481-9. PubMed ID: 16759033 [TBL] [Abstract][Full Text] [Related]
4. Statement 1: a serum insulin-like growth factor I (IGF-I) level should be part of the evaluation of children with short stature. Cohen P Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():834-6. PubMed ID: 18438325 [No Abstract] [Full Text] [Related]
5. Characterization of the IGF system in 15 patients with Alström syndrome. Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998 [TBL] [Abstract][Full Text] [Related]
6. Relationship between insulin-like growth factors (IGF-I and IGF-II), IGF-binding proteins (IGFBP-3, IGFBP-2), leptin and anthropometric parameters (height, body mass index) during antileukaemic treatment in children. Krawczuk-Rybak M; Muszyńska-Rosłan K; Kitszel A; Sawicka-Zukowska M; Wołczyński S Rocz Akad Med Bialymst; 2005; 50():208-11. PubMed ID: 16358968 [TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911 [TBL] [Abstract][Full Text] [Related]
8. Statement 3: a low serum IGF-I Level in idiopathic short stature patients indicates partial GH insensitivity. Bang P Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():841-6. PubMed ID: 18438327 [No Abstract] [Full Text] [Related]
9. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ; Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [TBL] [Abstract][Full Text] [Related]
10. The role of recombinant insulin-like growth factor I in the treatment of the short child. Rosenbloom AL Curr Opin Pediatr; 2007 Aug; 19(4):458-64. PubMed ID: 17630612 [TBL] [Abstract][Full Text] [Related]
11. Congenital growth hormone insensitivity syndromes and their relevance to idiopathic short stature. Clayton PE; Freeth JS; Norman MR Clin Endocrinol (Oxf); 1999 Mar; 50(3):275-83. PubMed ID: 10435051 [No Abstract] [Full Text] [Related]
12. Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 measurements in paediatric practice. Banerjee I; Clayton PE Pediatr Endocrinol Rev; 2006 Jun; 3(4):393-402. PubMed ID: 16816808 [TBL] [Abstract][Full Text] [Related]
13. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I. Backeljauw P Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329 [No Abstract] [Full Text] [Related]
14. IGF-I, IGFBP-3 and ALS generation test in Turner syndrome. Pessoa de Queiroz AN; Collett-Solberg PF; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM Growth Horm IGF Res; 2007 Jun; 17(3):254-60. PubMed ID: 17540594 [TBL] [Abstract][Full Text] [Related]
15. Assessment of insulin-like growth factor-I serum concentration as a screening procedure in diagnosing children with short stature. Smyczynska J; Lewinski A; Stawerska R; Hilczer M; Karasek M Neuro Endocrinol Lett; 2007 Jun; 28(3):274-8. PubMed ID: 17627261 [TBL] [Abstract][Full Text] [Related]
16. Measurement of serum 'free' or 'easily dissociable' insulin-like growth factor-1. Roch M; Williams J; Clark PM Ann Clin Biochem; 2003 Mar; 40(Pt 2):175-7. PubMed ID: 12662407 [TBL] [Abstract][Full Text] [Related]
17. The molecular basis of idiopathic short stature. Rosenfeld RG Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S3-5. PubMed ID: 16023877 [TBL] [Abstract][Full Text] [Related]